GlassScriptPhysician profile
Julia I Malis
NPI 1447516331
$2,544.85
in general payments reported to CMS, 2019-2025
31 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $220 · 2021: $382 · 2022: $788 · 2023: $366 · 2024: $294 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.89 |
| Education | $113.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $445.29 | 2019-2024 | |
| Astellas Pharma US INC | $333.34 | 2022-2025 | Veozah |
| Mayne Pharma Commercial LLC | $216.91 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $165.10 | 2019-2023 | |
| Exeltis, USA INC. | $155.55 | 2020-2025 | Slynd |
| Aspira Women'S Health INC | $123.64 | 2022-2024 | Ova1 |
| Coopersurgical, INC. | $120.60 | 2019-2025 | Paragard T 380a, Sos, Summit Doppler |
| Avion Pharmaceuticals | $104.60 | 2019-2023 | Balcoltra |
| Renovia INC | $93.69 | 2020 | |
| Organon LLC | $75.54 | 2021-2022 | |
| Millicent US INC | $74.23 | 2019-2024 | Intrarosa, Femring |
| Agile Therapeutics, INC. | $70.52 | 2021-2022 | |
| Evofem Biosciences, INC. | $63.43 | 2020-2022 | |
| Channel Medsystems, INC. | $62.40 | 2022 | |
| Daiichi Sankyo INC. | $43.56 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $41.40 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $39.20 | 2019 | |
| Exact Sciences Corporation | $38.75 | 2023-2024 | Cologuard Collection Kit |
| Scynexis, INC. | $36.60 | 2022 | |
| Shield Therapeutics INC | $35.34 | 2023 | Accrufer |
| Hologic Sales and Service, LLC | $33.26 | 2019-2025 | Aptima |
| Medtronic, INC. | $29.29 | 2022-2023 | Truclear |
| Mylan Pharmaceuticals INC. | $25.84 | 2022 | |
| Sumitomo Pharma America, INC. | $21.40 | 2025 | Myfembree |
| Avanos Medical | $15.94 | 2019 | |
| Biogen, INC. | $15.43 | 2024 | |
| Becton, Dickinson and Company | $14.70 | 2021 | |
| Pfizer INC. | $13.70 | 2023 | |
| Sanofi Pasteur INC. | $12.47 | 2019 | |
| Olympus America INC. | $11.95 | 2022 | |
| Vertical Pharmaceuticals, LLC | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Malis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.